The Prognostic Value of Pyrosequencing-Detected MGMT Promoter Hypermethylation in Newly Diagnosed Patients with Glioblastoma.
about
CDH22 hypermethylation is an independent prognostic biomarker in breast cancer.CHL1 hypermethylation as a potential biomarker of poor prognosis in breast cancer.Prognostic value of O-6-methylguanine-DNA methyltransferase (MGMT) protein expression in glioblastoma excluding nontumour cells from the analysis.Is the prognostic significance of O6-methylguanine- DNA methyltransferase promoter methylation equally important in glioblastomas of patients from different continents? A systematic review with meta-analysis.
P2860
The Prognostic Value of Pyrosequencing-Detected MGMT Promoter Hypermethylation in Newly Diagnosed Patients with Glioblastoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The Prognostic Value of Pyrose ...... ed Patients with Glioblastoma.
@ast
The Prognostic Value of Pyrose ...... ed Patients with Glioblastoma.
@en
type
label
The Prognostic Value of Pyrose ...... ed Patients with Glioblastoma.
@ast
The Prognostic Value of Pyrose ...... ed Patients with Glioblastoma.
@en
prefLabel
The Prognostic Value of Pyrose ...... ed Patients with Glioblastoma.
@ast
The Prognostic Value of Pyrose ...... ed Patients with Glioblastoma.
@en
P2093
P2860
P50
P356
P1433
P1476
The Prognostic Value of Pyrose ...... sed Patients with Glioblastoma
@en
P2093
Alessandra Fabi
Beatrice Casini
Carmine M Carapella
Luca Prosperini
Mariantonia Carosi
P2860
P304
P356
10.1155/2015/604719
P577
2015-08-11T00:00:00Z